Depigmentation activity of Deconstruct Vitamin C Gel Sunscreen

A single blind clinical study to evaluate the Depigmentation activity of Deconstruct Vitamin C Gel Sunscreen - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2026/02/104241

Enrollment

Registered

2026-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Deconstruct Vitamin C Gel Sunscreen: Test Product: Deconstruct Vitamin C Gel Sunscreen Dose:1 gm gel twice a day Route of Administration: Topical, Duration: 28days Contro

Eligibility

Inclusion criteria

Inclusion criteria: 1.Gender: Male or Female with age 18-45. 2.Mild to Moderate pigmentation issues. 3.Subject willing to give written informed consent 4.Women of child bearing potential must have a negative urine pregnancy test 5.Free of any systemic and dermatologic disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1.Subjects who are pregnant, breast feeding, or planning to become pregnant during the study 2.Volunteers with skin conditions such as eczema, psoriasis 3.Have any evidence of systematic cancer, squamous cell carcinoma, basal cell carcinoma in the last 5 years, or any other confounding skin condition. 4.Have open sore or open lesions in the treatment area 5.Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product. 6.Have participated in any interventional clinical trial in the previous 30 days. 7.Have a known sensitivity to any of the constituents of the test product including sensitivities to any of the constituents. 8.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medications (i.e., biologics), including corticosteroids. Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years.

Design outcomes

Primary

Measure	Time frame
1. Change in skin Gloss 2. Change in Hydration 3. Change in TEWL 4. Change in Melanin Index 5. Change in Skin Colour 6. Change in dark spots 7. Change in skin texture 8. Change in smoothness 9. Change in skin even toneTimepoint: Day 0, Day 14, Day 28	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results